BiotechTube

RHB-105 + Placebo

Phase 3Completed
0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Dyspepsia

Conditions

Dyspepsia, Helicobacter Pylori Infection

Trial Timeline

Nov 1, 2013 → Aug 1, 2015

NCT ID
NCT01980095

About RHB-105 + Placebo

RHB-105 + Placebo is a phase 3 stage product being developed by RedHill Biopharma for Dyspepsia. The current trial status is completed. This product is registered under clinical trial identifier NCT01980095. Target conditions include Dyspepsia, Helicobacter Pylori Infection.

What happened to similar drugs?

3 of 15 similar drugs in Dyspepsia were approved

Approved (3) Terminated (3) Active (11)
✅esomeprazoleAstraZenecaApproved
✅Esomeprazole MagnesiumAstraZenecaApproved
✅Tegaserod and PlaceboNovartisApproved
🔄YM443Astellas PharmaPhase 3
🔄Cinitapride + domperidoneEisaiPhase 3
🔄Z-338Zeria PharmaceuticalPhase 3
🔄Imonogas + EspumisanJohnson & JohnsonPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
5
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01980095Phase 3Completed

Competing Products

20 competing products in Dyspepsia

See all competitors
ProductCompanyStageHype Score
YH12852 0.1 mg + YH12852 0.25 mg + YH12852 0.5 mg + PlaceboYuhanPhase 2
27
YM443 + Placebo + MoxifloxacinAstellas PharmaPhase 1
29
YM443Astellas PharmaPhase 3
40
Cinitapride + domperidoneEisaiPhase 3
40
Rabeprazole + Rabeprazole + Rabeprazole + PlaceboEisaiPhase 2
35
Z-338Zeria PharmaceuticalPhase 3
40
Imonogas + EspumisanJohnson & JohnsonPhase 3
40
esomeprazoleAstraZenecaApproved
43
Esomeprazole MagnesiumAstraZenecaApproved
35
TegaserodNovartisPhase 3
40
TegaserodNovartisPhase 3
40
TegaserodNovartisPhase 3
40
Tegaserod and PlaceboNovartisApproved
35
TegaserodNovartisPhase 3
40
TegaserodNovartisPhase 3
40
Gabapentin + PlaceboPfizerPhase 3
32
Z-338Zeria PharmaceuticalPhase 2
35
Z-338Zeria PharmaceuticalPhase 2
35
Z-338Zeria PharmaceuticalPhase 2
35
Z-338 + PlaceboZeria PharmaceuticalPhase 3
40